Clinical Trials

Accrual Status
Limit to SWOG Trials

1032 Results

View
Closed
Phase
Accrual
100%
SWOG Clinical Trial Number
S1008

Feasibility Study of a Physical Activity and Dietary Change Weight Loss Intervention In Breast and Colorectal Cancer Survivors, Phase II
Research Committee(s)
Cancer Survivorship
Breast Cancer
Gastrointestinal Cancer
Activated
03-01-2012
Closed
07-01-2014
ClinicalTrials.gov Registry Number
NCT01453452
Closed
Phase
Accrual
100%
Published
SWOG Clinical Trial Number
S1117

A Randomized Phase II Study of Azacitidine in Combination with Lenalidomide (NSC-703813) vs. Azacitidine Alone vs. Azacitidine in Combination with Vorinostat (NSC-701852) for Higher-Risk Myelodysplastic Syndromes (MDS) and Chronic Myelomonocytic Leukemia (CMML)
Research Committee(s)
Leukemia
Activated
03-01-2012
Closed
11-14-2014
ClinicalTrials.gov Registry Number
NCT01522976
Closed
Phase
Accrual
95%
SWOG Clinical Trial Number
S1201

A Randomized Phase II Pilot Study Prospectively Evaulating Treatment for Patients Based on ERCC1 (Excision Repair Cross-Complementing 1) for Advanced/Metastatic Esophageal, Gastric or Gastroesophageal Junction (GEJ) Cancer
Research Committee(s)
Gastrointestinal Cancer
Activated
02-08-2012
Closed
04-01-2015
ClinicalTrials.gov Registry Number
NCT01498289
Closed
Phase
Accrual
100%
Published
SWOG Clinical Trial Number
S0927

Randomized Placebo-Controlled Trial of Omega-3-Fatty Acid for the Control of Aromatase Inhibitor-Induced Musculoskeletal Pain in Women with Early Stage Breast Cancer, Phase III
Research Committee(s)
Symptom Control and Quality of Life
Breast Cancer
Activated
02-01-2012
Closed
02-01-2013
ClinicalTrials.gov Registry Number
NCT01385137
Closed
Phase
Accrual
100%
Published
SWOG Clinical Trial Number
S1119

Gastric Cancer and Helicobacter Pylori Infection in Lima, Peru: The Role of Water Contamination
Research Committee(s)
Prevention & Epidemiology
Activated
12-02-2011
Closed
08-05-2013
ClinicalTrials.gov Registry Number
NCT01512875
Closed
Phase
Accrual
94%
SWOG Clinical Trial Number
S1013

A Phase II Prospective Study of Epidermal Growth Factor Receptor (Her-1/EGFR) Inhibitor-Induced Dermatologic Toxicity: Validation of the Functional Assessment of Cancer Therapy � EGFRI 18 (FACT-EGFRI 18) Questionnaire for EGFRI-induced Skin Toxicities
Status Notes
This study will be permanently closed to accrual on October 1, 2016, at 11:59 p.m. Pacific.
Research Committee(s)
Symptom Control and Quality of Life
Gastrointestinal Cancer
Lung Cancer
Activated
11-15-2011
Closed
10-01-2016
ClinicalTrials.gov Registry Number
NCT01416688
Closed
Phase
Accrual
95%
SWOG Clinical Trial Number
S0812

“Phase IIB Randomized Controlled Biomarker Modulation Study of Vitamin D in Premenopausal Women at High Risk for Breast Cancer."
Research Committee(s)
Prevention & Epidemiology
Breast Cancer
Activated
11-01-2011
Closed
08-15-2014
ClinicalTrials.gov Registry Number
NCT01097278
Closed
Phase
Accrual
100%
Published
SWOG Clinical Trial Number
S1108

Phase II Trial of the Aurora Kinase A Inhibitor, MLN8237, in Peripheral T-Cell Non-Hodgkin Lymphoma
Research Committee(s)
Lymphoma
Activated
10-28-2011
Closed
06-06-2013
Closed
Phase
Accrual
29%
Published
SWOG Clinical Trial Number
S1106

A Randomized Phase II Trial of R-HCVAD-MTX/ARA-C Induction Followed by Consolidation With an Autologous Stem Cell Transplant vs. R-Bendamustine Induction Followed by Consolidation With an Autologous Stem Cell Transplant for Patients </= 65 Years of Age With Previously Untreated Mantle Cell Lymphoma
Research Committee(s)
Lymphoma
Activated
10-01-2011
Closed
06-26-2013
ClinicalTrials.gov Registry Number
NCT01412879
Closed
Phase
Accrual
98%
Published
SWOG Clinical Trial Number
S1014

Abiraterone Acetate Treatment for Prostate Cancer Patients with a PSA of More Than Four Following Initial Androgen Deprivation Therapy, Phase II.
Research Committee(s)
Genitourinary Cancer
Activated
08-09-2011
Closed
08-01-2013
ClinicalTrials.gov Registry Number
NCT01309672
Closed
Phase
Accrual
100%
SWOG Clinical Trial Number
S1011

A Phase III Surgical Trial to Evaluate The Benefit Of A Standard Versus An Extended Pelvic Lymphadenectomy Performed At Time Of Radical Cystectomy For Muscle Invasive Urothelial Cancer
Research Committee(s)
Genitourinary Cancer
Activated
08-01-2011
Closed
04-15-2017
ClinicalTrials.gov Registry Number
NCT01224665
Closed
Phase
Accrual
100%
SWOG Clinical Trial Number
S1001

A Phase II Trial of PET-Directed Therapy for Limited Stage Diffuse Large B-cell Lymphoma (DLBCL)
Status Notes
Permanent Closure - Step 1 Registration Effective 6/1/2016 at 11:59 p.m. PST
Step 2 registration was permanently closed to accrual effective 11/30/17.
Research Committee(s)
Lymphoma
Activated
07-18-2011
Closed
06-01-2016
ClinicalTrials.gov Registry Number
NCT01359592
Closed
Phase
Accrual
100%
SWOG Clinical Trial Number
S0931

EVEREST: EVErolimus for Renal Cancer Ensuing Surgical Therapy, A Phase III Study.
Research Committee(s)
Genitourinary Cancer
Activated
04-01-2011
Closed
09-15-2016
ClinicalTrials.gov Registry Number
NCT01120249
Closed
Phase
Accrual
0%
SWOG Clinical Trial Number
S0833

Modified Total Therapy 3 (TT3) for Newly Diagnosed Patients with Multiple Myeloma (MM): A Phase II SWOG Trial for Patients Aged </= 65 Years
Research Committee(s)
Myeloma
Activated
03-15-2011
Closed
05-01-2012
Closed
Phase
Accrual
100%
SWOG Clinical Trial Number
S1007

A Phase III, Randomized Clinical Trial of Standard Adjuvant Endocrine Therapy +/- Chemotherapy in Patients with 1-3 Positive Nodes, Hormone-responsive and Her2-Negative Breast Cancer according to Recurrence Score (RS).
Status Notes
4/9/21: S1007 Revision #16 protocol and supporting documents are being distributed to sites to begin the participating site implementation process. S1007 Revision #16 is CIRB approved, however SWOG is awaiting final contract execution with the processing laboratories in order to activate the Circulating Biomarker Assessment for Late Relapse Translational Medicine (CBALR TM) Substudy (Registration Step 3) to enrollment. A forthcoming memorandum will be distributed (anticipated May 2021) to activate the S1007 CBALR TM Substudy (Registration Step 3) and the provision of sample collection kits (as indicated in protocol Section 15.3b).

Step 1 Registration was closed to accrual effective October 1, 2015 and Step 2 Registration was closed to accrual effective October 15, 2015.
Research Committee(s)
Breast Cancer
Activated
01-15-2011
ClinicalTrials.gov Registry Number
NCT01272037
Closed
Phase
Accrual
100%
Published
SWOG Clinical Trial Number
S1005

A Phase II Study of MK-2206 (NSC-749607) as Second Line Therapy for Advanced Gastric and Gastroesophageal Junction Cancer
Research Committee(s)
Gastrointestinal Cancer
Activated
01-01-2011
Closed
05-01-2013
Closed
Phase
Accrual
100%
Published
SWOG Clinical Trial Number
S0925

A Randomized Phase II Study of Androgen Deprivation Combined with IMC-A12 Versus Androgen Deprivation Alone for Patients with New Hormone-Sensitive Metastatic Prostate Cancer
Research Committee(s)
Genitourinary Cancer
Activated
12-15-2010
Closed
12-01-2012
ClinicalTrials.gov Registry Number
NCT01120236
Closed
Phase
Accrual
100%
Published
SWOG Clinical Trial Number
S0806

A Phase I/II Trial of Vorinostat (SAHA) (NSC-701852) in Combination with Rituximab-CHOP in Patients with Newly Diagnosed Advanced Stage Diffuse Large B-Cell Lymphoma (DLBCL)
Research Committee(s)
Lymphoma
Activated
11-15-2010
Closed
10-01-2013
ClinicalTrials.gov Registry Number
NCT00972478
Closed
Phase
Accrual
45%
Published
SWOG Clinical Trial Number
S0933

Phase II Study of RO4929097 (NSC-749225) in Advanced Melanoma
Research Committee(s)
Melanoma
Activated
10-28-2010
Closed
11-15-2011
ClinicalTrials.gov Registry Number
NCT01120275
Closed
Phase
Accrual
100%
Published
SWOG Clinical Trial Number
S0910

A Phase II Study of Epratuzumab in Combination with Cytarabine and Clofarabine for Patients with Relapsed or Refractory Precursor B-cell Acute Lymphoblastic Leukemia
Research Committee(s)
Leukemia
Activated
08-15-2010
Closed
07-01-2012